loading page

Recombinant von Willebrand factor for perioperative bleeding management in pediatric patient with allergy to plasma-derived von Willebrand factor
  • +1
  • Thuy Tran,
  • Justin Arnall,
  • Brendan Kleiboer,
  • Ashley Hinson
Thuy Tran
Atrium Health

Corresponding Author:[email protected]

Author Profile
Justin Arnall
Atrium Health
Author Profile
Brendan Kleiboer
Atrium Health
Author Profile
Ashley Hinson
Levine Children's Hospital
Author Profile

Abstract

Von Willebrand disease (VWD) is a hereditary bleeding disorder characterized by a deficiency of von Willebrand factor (VWF). In pediatrics, plasma-derived VWF (pdVWF) is the standard for factor replacement when indicated. Alternatives are needed for kids who are refractory or intolerant to pdVWF. There is limited data on the safety and efficacy of recombinant VWF in the pediatric population, and none regarding the switch from pdVWF to rVWF due to intolerance. Herein, we describe the safe and effective use of rVWF in a pediatric patient with history of anaphylaxis to pdVWF, who underwent elective orthopedic surgery.
04 Aug 2022Published in Pediatric Blood & Cancer. 10.1002/pbc.29918